Granulomatous Lymphocyte Interstitial Lung Disease: A Rare Complication of Common Variable Immunodeficiency Managed With Azathioprine and Rituximab.

Authors

Ali Khreisat, Corewell Health East Resident
Vickie Xin, Corewell Health East Resident
Christopher Dado, Corewell Health East

Document Type

Article

Publication Date

4-30-2024

Publication Title

Cureus

Abstract

Granulomatous lymphocytic interstitial lung disease (GL-ILD) is a rare, non-infectious pulmonary manifestation of common variable immunodeficiency (CVID). Diagnosing and managing GLILD remains challenging due to its poorly understood pathogenesis and high mortality. We present a complex case of a young female with CVID associated with lung and spinal cord involvement managed with azathioprine and rituximab.

Volume

16

Issue

4

First Page

e59399

Recommended Citation

Khreisat A, Xin V, Dado C. Granulomatous lymphocyte interstitial lung disease: a rare complication of common variable immunodeficiency managed with azathioprine and rituximab. Cureus. 2024 Apr 30;16(4):e59399. doi: 10.7759/cureus.59399. PMID: 38689676

DOI

10.7759/cureus.59399

ISSN

2168-8184

PubMed ID

38689676